Zweig-DiMenna Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Zweig-DiMenna Associates’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-84,683	Closed	-$1.06M	–	129
2019 Q1	$1.06M	Sell	84,683 -18,324	-18%	-$245K	0.12%	90
2018 Q4	$1.17M	Sell	103,007 -120,000	-54%	-$1.88M	0.12%	94
2018 Q3	$4.17M	Hold	223,007	–	–	0.35%	84
2018 Q2	$5.76M	Buy	+223,007	New	+$5.79M	0.35%	83
2018 Q1	–	Sell	-131,505	Closed	-$3.29M	–	184
2017 Q4	$3.29M	Buy	+131,505	New	+$3.22M	0.36%	73
2017 Q3	–	Sell	-186,880	Closed	-$3.78M	–	252
2017 Q2	$3.78M	Buy	+186,880	New	+$3.89M	0.28%	97

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Zweig-DiMenna Associates's FLXN Position: Q2 2019 in Review

Zweig-DiMenna Associates sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 84,683 shares — an estimated $1.06M sold.

Zweig-DiMenna Associates first reported a position in FLXN in Q2 2017 and held it in 6 quarters. The position peaked at $5.76M in Q2 2018. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

Zweig-DiMenna Associates reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Zweig-DiMenna Associates sold 84,683 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $1.06M.
Zweig-DiMenna Associates first reported a position in Flexion Therapeutics, Inc. in Q2 2017 and held it in 6 quarters.
Zweig-DiMenna Associates's Flexion Therapeutics, Inc. position peaked at $5.76M in Q2 2018.
129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2019, filed 10 Jul 2019.